|
Dec 21
|
HOOKIPA Pharma Announces $21.25 Million Equity Investment from Gilead Sciences
|
|
Nov 3
|
HOOKIPA Pharma Presents Positive Biomarker and Translational Data on HB-200 Monotherapy at Society for Immunotherapy of Cancer 2023
|
|
Nov 2
|
HOOKIPA Pharma to Report Third Quarter 2023 Financial Results and Recent Business Highlights on November 9, 2023
|